Evidence map›Paper›PMID 38303543›Full record

ArticleInternational journal of surgical pathology2024

Isidro Machado, Yanming Zhang, Meera Hameed, Sinchun Hwang, Aarti E Sharma, Mark H Bilsky, Konstantinos Linos

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of surgical pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Isidro MachadoDepartment of Pathology, Instituto Valenciano de Oncología, Valencia, Spain.ORCID 0000-0001-7318-1330
Yanming ZhangDepartment of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Meera HameedDepartment of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sinchun HwangDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Aarti E SharmaDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mark H BilskyDepartment of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Konstantinos LinosDepartment of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USBrigham and Women's Hospital · USUniversitat de València · ES

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The clinical, radiological, and histopathological features of chondromyxoid fibroma can sometimes resemble those of other benign or malignant tumors. Recently, recurrent

Indexed as

Biomarkers, TumorFibroblast Growth Factor-23Fibroblast Growth FactorsFibromaReceptors, Metabotropic GlutamateAdultFemaleGene RearrangementHumansImmunohistochemistryBiomarkers, TumorFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factorsmetabotropic glutamate receptor type 1Receptors, Metabotropic Glutamatechondromyxoid fibromaFGF23FN1GRM1phosphaturic mesenchymal tumor

Identifiers

PMID38303543
PMCPMC12060777
OpenAlexW4391483165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.